What is the prevalence and most common symptom of an allergy to mirabegron (Myrbetriq)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mirabegron Allergy Profile

True allergic reactions to mirabegron (Myrbetriq) are uncommon, and when they occur, the most common allergic symptom is urticaria (hives). 1

Prevalence of Allergic Reactions

  • Allergic reactions to mirabegron are rare compared to other drug classes such as platinum-based chemotherapy agents or certain antibiotics. 2
  • The FDA drug label documents specific allergic-type reactions occurring in less than 1% of patients treated with mirabegron in clinical trials. 1
  • In large-scale clinical trials involving 2,736 patients receiving mirabegron for 12 weeks, true allergic/hypersensitivity reactions were infrequent adverse events. 1

Most Common Allergic Symptoms

When allergic reactions do occur with mirabegron, the documented allergic-type manifestations include:

  • Urticaria (hives) - the most commonly documented allergic-type skin reaction 2, 1
  • Rash and pruritus (itching) 2, 1
  • Lip edema 2, 1
  • Leukocytoclastic vasculitis - a more serious but rare allergic reaction 2, 1
  • Purpura 2, 1

Important Clinical Distinction

It is critical to distinguish true allergic reactions from common adverse effects, which are NOT allergic in nature:

  • The most frequently reported adverse reactions to mirabegron are hypertension (7.5-11.3%), nasopharyngitis (3.5-3.9%), urinary tract infections (2.9-4.2%), and headache (2.1-3.2%) - these are pharmacologic effects, not allergic reactions. 2, 1
  • These common adverse effects occur at rates only slightly higher than placebo and do not represent drug allergy. 1

Angioedema Risk

  • Angioedema is a rare but serious potential allergic reaction that can involve the tongue, hypopharynx, or larynx. 1
  • If angioedema involving the tongue, hypopharynx, or larynx occurs, immediately discontinue mirabegron and provide appropriate therapy to ensure a patent airway. 1
  • This represents a true medical emergency requiring prompt intervention. 1

Clinical Context

  • Real-world pharmacovigilance data from 18,763 adverse event reports identified unexpected reactions including lip swelling and swollen tongue, which may represent allergic phenomena. 3
  • Mirabegron has a substantially lower allergic reaction profile compared to medications like carboplatin (which causes allergic reactions in 16% of patients) or fluoroquinolone antibiotics. 4, 2
  • The overall tolerability profile of mirabegron is favorable, with most patients experiencing no allergic reactions whatsoever. 5, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.